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Local Hyperthermia and Radiation
A biologically-oriented clinical scheduling
G. Arcangeli MD* and A. Cividalli, D.Sc**

In a series of animal tumor studies, heat was directly
delivered into the tumor mass with an interstitial applicator. After hyperthermia (44°-45°C for 45 minutes) or radiation alone (3x10 Gy), only a slight delay in tumor growth
was observed, while the combined treatment, either simultaneous or sequential (i.e., heat delivered four hours after
irradiation), appeared to be the most effective. The cure
rate in the two combined treatment groups was 100%, in
contrast to the lack of cure in the first two groups. The
simultaneous use of heat and x-ray appeared to be slightly
more effective than the sequential schedule; in all cases, no
increase in radiation effects on normal tissue could be
observed.

patient. All patients were irradiated according to a multiple
daily fractionation (MDE) scheme (24-7.5-1-?.5 Gy/day, 4hour intervals, 5 days/week), and hyperthermia (42°-43°C,
45 minutes) was delivered every other day Immediately
after the second daily radiation fraction, by means of an
external applicator operating at 500 MHz. With this schedule, heat is delivered simultaneously with the second and
sequentially with the first and third radiation fractions. In
halfthe patients, misonidazole was also administered (1.2
g/m^ up to a total dose of 12 g/m^). The data indicate that
multimodality treatments seem to be more effective than
conventional fractionation or MDF alone. In particular, the
best response was obtained when MDF was combined with
both misonidazole and hyperthermia. No increased radiation reactions have ever been observed in patients treated
with hyperthermia also; all side effects depend mainly on
misonidazole toxicity.

For clinical studies, 47 patients with a total of 101 neck
node metastases from head and neck cancer have been
treated in order to compare tumor response to at least two
different combinations of treatment modalities in the same

tissues are heated at the same temperature. This finding
was confirmed by other authors (2,3) with the suggestion
that under these circumstances heat should be delivered
three to six hours after x-rays.

Biological Rationale
In the last few years basic investigations on cytotoxic and
radiosensitizing mechanisms have led to a resurgence of
interest in hyperthermia alone or in combination with
radiotherapy as a means of treating malignant tumors.

Furthermore, it is well known that above a critical temperature of about 43°C the synergistic interaction between heat
and x-rays is due to an increase in the expression of lethal
damage on both normal and neoplastic cells. Near 45°C
hyperthermia inactivation seems to be mainly ascribed to
the aspecific process of protein denaturation. Once again,
temperatures above 43°C, although more effective, appear
to be clinically useful only in situations in which tumors
can be heated selectively or preferentially with respect to
the surrounding normal tissues.

Some measure of agreement now exists among investigators on optimum fractionation and sequence of radiation
and heat. Overgaard (1) has recently demonstrated in animal tumors that a simultaneous treatment is therapeutically
advantageous in situations in which tumors can be heated
selectively or preferentially apart from the surrounding
normal tissues, while sequential treatment has its potential
in situations in which tumors and surrounding normal

Animal Studies
By e m p l o y i n g our interstitial applicator described
elsewhere (4,5), we selectively heated small volumes of
tumor tissue, as shown in Fig. 1, in mice at temperatures
around 45°C. With these techniques, several multimodality
treatment schedules could be tested on a relatively radio-
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Fig. 1
In vivo temperature distribution obtained at 20 min. from the beginning
of heating by an interstitial applicator operated at 500 M H z .
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resistant fibrosarcoma of spontaneous origin that had been
transplanted in the thighs of mice. Treatment was started
eight to ten days after inoculation:
1) heat alone (44°-45°C, 45 minutes) on Monday, Thursday, and Monday;
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2) radiation alone (10 Gy*) on Monday, Thursday, and
Monday;

J-

10

14

18

22

26

30

34 days

Fig. 2
The effect of several treatment modalities on a fibrosarcoma of spontaneous origin, transplanted in the thigh of mice. — Control growth
curve; • = Heat alone; • = Radiation alone; • = Sequential radiation
and heat; o =. Simultaneous radiation and heat.

3) simultaneous radiation and heat (heat delivered immediately after irradiation according to 1) and 2));
4) sequential radiation and heat (heat delivered four
hours after irradiation according to 1) and 2)).

Clinical Studies

In Fig. 2, the effect of heat alone, radiation alone, and
combined treatment is compared with the control growth
curve. After hyperthermia or irradiation alone, tumor
growth was only slightly delayed. Heat combined with
radiation appears to be the most effective treatment schedule, as a 100% cure rate was observed in contrast to the
absence of cure in the first two groups. Also, the simultaneous use of heat and x-rays appears to be more effective
than the sequential schedule, even though in both groups
the effect can surely be defined as supra-additive.

In our treatment schedules, hyperthermia is delivered immediately after the second fraction of a thrice daily fractionation course of radiotherapy. Heat is delivered
simultaneously with the second, and sequentially with the
first and the third radiation fractions. This treatment schedule represents a compromise between the nondifferential,
radiosensitizing effect of simultaneous treatment on both
neoplastic and normal tissue and the more selective
cytotoxic effect of a sequential treatment on tumors.
The aim of our study was to treat comparable lesions in the
same patients with at least two different combinations of
treatment modalities. For this purpose, we selected 47
patients with a total of 101 neck node metastases (N2- N3)
from head and neck cancer.

These results clearly favor the use of hyperthermia and
radiation simultaneously when heat can be properly delivered to the tumor mass. When care is exercised in the heat
treatment, the simultaneous use of hyperthermia and radiation does not produce any increased radiation effects on
normal tissues.

Irradiation
All patients were irradiated with a 5.7 MeV photon beam,
through an anterior field that covered the whole neck or
through two cross-firing portals when concomitant treatment of the primary tumor was required. Patients were
irradiated accordingto a multiple daily fractionation (MDF)

Gy = Cray; 1 Gy = 100 rad
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patients treated w i t h c o n v e n t i o n a l fractionation of 2
Gy/day. With respect to this control group, all data in other
protocols indicate an increase of local response, especially
in the groups treated also with hyperthermia. When the
percentof successes in surviving patients is plotted against
the period of observation (Fig. 3), local control rate in the
two basic categories (MDF and MDF 4- MIS) appears to be
better than that in the control group of conventional fractionation, although a statistically significant difference
(0.05>p>0.01) could be demonstrated only in the second
category of patients treated with MDF 4- MIS, and only at
the end of treatment Naturally, no statistical difference
c o u l d be calculated between the t w o basic treatment
groups. When hyperthermia was delivered also (Fig. 4), the
local control rate was even better and seemed to remain at
the same level through the follow-up period, suggesting
that recurrence is rarely a cause of death in these latter
groups. At the end of treatment, the results obtained in
patients treated with hyperthermia were also statistically
different not only from the historical series (0.05>p>0.01)
but also from the group treated with MDF alone (p<0.05).
Unfortunately, because many of these patients died, itwas
not possible to calculate a statistical difference at 12
months between the group treated with MDF alone and
those treated with heat also, although in the latter a statistically significant difference (p<0.05) could be seen when
compared to the historical series treated with conventional
fractionation.

scheme, as described elsewhere (6). It consisted of
2-1-1.5-1-1.5 Gy/day, four-hour intervals between fractions,
five days/week, up to a total dose of 40-70 Cy.
Hyperthermia
Hyperthermia (HT) was induced in patients by our TUETT
500 apparatus with an external applicator operated at 500
M H z (7). Temperature was monitored every 10 minutes at
the tumor center by means of thermocouples inserted
through teflon cannulae previously positioned into the
node. Heat was delivered on Monday, Wednesday, and
Friday of each week, immediately after the second daily
fraction, at a temperature of about 42°-43°C.
Misonidazole (MIS)
In about half the patients, a hypoxic cell sensitizer (misonidazole, provided by courtesy of the Prodotti Roche,
Milan, Italy) was also employed. The drug was orally
administered in a 1.2 g/m^ dose two hours before the first
daily fraction of radiation, for 10 treatment days, up to a
total dose of 12 g/m^
Response evaluation and treatment protocols
The volume of the lesions under treatment was weekly
estimated by measuring in three planes. Complete response was defined as reduction of tumors to less than
palpable size. Patients were assigned to one of the two
basic treatment groups (MDF alone and MDF 4- MIS), and
heat was delivered to one of the nodes in each patient, so
that all lesions were treated according to the following
treatment protocols:
1) MDF
2) MDF + MIS

Alone
HT
Alone
HT

32
27
22
27

No increased radiation reactions have ever been observed
in patients treated with hyperthermia. In two patients, some
skin burns, which rapidly healed, were observed at the
beginning of this study, due to the use of an improper
applicator. Other side effects have been observed only in
patients treated with MIS as well. These consisted of mild
nausea (75%), which was easily controlled by methoclopramide, generalized skin papillary rashes (two patients
removed from protocol), and mild peripheral neuropathy
(10%). Furthermore, in the misonidazole group all four
patients irradiated through two cross-firing portals experienced oropharyngeal mucositis that occurred earlier,
longer, and stronger than in the patients treated through the
same portals with MDF alone.

nodes
nodes
nodes
nodes

Results
The results at 12 months' follow-up, obtained with different
treatment protocols, are shown in Table I and are also
compared with those obtained in our historical series of

TABLE I
R e s u l t s of Different Treatment Protocols
Complete Response
at 12 Months

MDF
alone

M D F -I- HT

MDF + MIS
alone

MDF -I- MIS
+ HT

Conventional
Fractionation

Crude

7/32 (.22)

11/27 (.41)

7/22 (.32)

8/20 (.40)

6/46 (.13)

Actuarial

7/16 (.44)

11/15 (.73)

7/12 (.58)

8/10 (.80)

6/28 (.21)

MDF = multiple daily fractionation
HT = hyperthermia
MIS = misonidazole
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Fig. 3
Local control rate in patients of the t w o basic treatment categories (MDF
and MDF -I- MIS), surviving at the time of observation. •
0 =
R a d i a t i o n a l o n e ( c o n v e n t i o n a l f r a c t i o n a t i o n ; h i s t o r i c a l series);
A
A = Radiation alone (MDF: 2-1-1.5-1- 1.5 Gy/day, 4 h intervals,
5 days/week); AA = Radiation (MDF) + Misonidazole (MIS: 1.2
g/m^ daily, for 10 treatment days).

Fig. 4
Local control rate in patients treated w i t h hyperthermia also, surviving at
the time of observation. •
• = Radiation alone (conventional
fractionation; historical series) •
• = Radiation alone (MDF);
A
A = M D F -I- Heat (HT: 4 r - 4 3 ° C , 45 min, immediately after the
second daily fraction of radiation, on days 1, 3, and 5 of each week);
A
A = MDF -F HT -1- MIS.

Discussion
Our experimental and clinical results clearly show the
increased effect of ionizing radiation on tumors by means
of hyperthermia. Whether heat delivered sequentially (e.g.,
four hours later) with respect to radiation is therapeutically
more advantageous than heat administered simultaneously
with radiation is still to be proved, especially when late
effects to normal tissue are considered. However, our
results on mouse tumors heated wfth an interstitial applicator indicate that the use of hyperthermia and radiation
simultaneously is therapeutically superior when heat can
be preferentially delivered to the tumor mass.

tween simultaneous and sequential heat delivery, the most
important observation of our study is that this treatment
modality causes very little toxicity in patients. The absence
of increased normal epithelial tissue reaction is encouraging, even though more precise experimental and clinical
studies of the heat sequence and duration are still necessary, especially in regard to nonreversible late injury to
normal tissues.
Local tumor control also appears to be improved when
hyperthermia was also applied to the two basic categories
of treatment (MDF and MDF -F MIS), thus confirming that
hyperthermia can be a useful tool for enhancing radiation
response in human tumors.

Although our treatment schedule of combined hyperthermia and radiation can be considered a compromise be-
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